{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:26Z","timestamp":1786982246260,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Society for the study of liver diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12072-022-10361-4","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T14:02:56Z","timestamp":1654610576000},"page":"944-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Propranolol vs. band ligation for primary prophylaxis of variceal hemorrhage in cirrhotic patients with ascites: a randomized controlled trial"],"prefix":"10.1007","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct02649335","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9113-5167","authenticated-orcid":false,"given":"Virendra","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipun","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Vijayvergiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"10361_CR1","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","volume":"4","author":"R Planas","year":"2006","unstructured":"Planas R, Montoliu S, Ballest\u00e9 B, Rivera M, Miquel M, Masnou H, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006;4:1385\u20131394","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10361_CR2","doi-asserted-by":"publisher","unstructured":"North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med. 1988;319(15):983\u20139. https:\/\/doi.org\/10.1056\/NEJM198810133191505. PMID: 3262200","DOI":"10.1056\/NEJM198810133191505"},{"key":"10361_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310\u2013335","journal-title":"Hepatology"},{"key":"10361_CR4","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","volume":"393","author":"C Villanueva","year":"2019","unstructured":"Villanueva C, Albillos A, Genesc\u00e0 J, Garcia-Pagan JC, Calleja JL, Aracil C, et al. \u03b2 Blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393:1597\u20131608","journal-title":"Lancet"},{"key":"10361_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.12.001","volume":"2","author":"SG Rodrigues","year":"2020","unstructured":"Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: evidence-based indications and limitations. JHEP Rep. 2020;2: 100063","journal-title":"JHEP Rep"},{"key":"10361_CR6","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJM199105303242202","volume":"324","author":"T Poynard","year":"1991","unstructured":"Poynard T, Cal\u00e8s P, Pasta L, Ideo G, Pascal JP, Pagliaro L, et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med. 1991;324:1532\u20131538","journal-title":"N Engl J Med"},{"key":"10361_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/s-2007-1007133","volume":"19","author":"G D'Amico","year":"1999","unstructured":"D\u2019Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999;19:475\u2013505","journal-title":"Semin Liver Dis"},{"key":"10361_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.23775","volume":"52","author":"T Serst\u00e9","year":"2010","unstructured":"Serst\u00e9 T, Melot C, Francoz C, Durand F, Rautou PE, Valla D, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010;52:1017\u20131022","journal-title":"Hepatology"},{"key":"10361_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jhep.2016.01.031","volume":"64","author":"BS Madsen","year":"2016","unstructured":"Madsen BS, Nielsen KF, Fialla AD, Krag A. Keep the sick from harm in spontaneous bacterial peritonitis: dose of beta blockers matters. J Hepatol. 2016;64:1455\u20131456","journal-title":"J Hepatol"},{"key":"10361_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/lt.24744","volume":"23","author":"SG Kim","year":"2017","unstructured":"Kim SG, Larson JJ, Lee JS, Therneau TM, Kim WR. Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates. Liver Transpl. 2017;23:733\u2013740","journal-title":"Liver Transpl"},{"key":"10361_CR11","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/hep.28575","volume":"64","author":"GN Kalambokis","year":"2016","unstructured":"Kalambokis GN, Christodoulou D, Baltayiannis G, Christou L. Propranolol use beyond 6 months increases mortality in patients with Child-Pugh C cirrhosis and ascites. Hepatology. 2016;64:1806\u20131808","journal-title":"Hepatology"},{"key":"10361_CR12","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","volume":"146","author":"M Mandorfer","year":"2014","unstructured":"Mandorfer M, Bota S, Schwabl P, Bucsics T, Pfisterer N, Kruzik M, et al. Nonselective \u03b2 blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology. 2014;146:1680-1690.e1681","journal-title":"Gastroenterology"},{"key":"10361_CR13","first-page":"1304","volume":"36","author":"UC Bang","year":"2016","unstructured":"Bang UC, Benfield T, Hyldstrup L, Jensen JE, Bendtsen F. Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers. Liver Int Off J Int Assoc Study Liver. 2016;36:1304\u20131312","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10361_CR14","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1002\/hep.28352","volume":"63","author":"L Bossen","year":"2016","unstructured":"Bossen L, Krag A, Vilstrup H, Watson H, Jepsen P. Nonselective \u03b2-blockers do not affect mortality in cirrhosis patients with ascites: post hoc analysis of three randomized controlled trials with 1198 patients. Hepatology. 2016;63:1968\u20131976","journal-title":"Hepatology"},{"key":"10361_CR15","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.cgh.2016.01.012","volume":"14","author":"S Chirapongsathorn","year":"2016","unstructured":"Chirapongsathorn S, Valentin N, Alahdab F, Krittanawong C, Erwin PJ, Murad MH, et al. Nonselective \u03b2-blockers and survival in patients with cirrhosis and ascites: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14:1096-1104.e1099","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10361_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","volume":"61","author":"A Krag","year":"2012","unstructured":"Krag A, Wiest R, Albillos A, Gluud LL. The window hypothesis: haemodynamic and non-haemodynamic effects of \u03b2-blockers improve survival of patients with cirrhosis during a window in the disease. Gut. 2012;61:967\u2013969","journal-title":"Gut"},{"key":"10361_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/apt.15439","volume":"50","author":"TL Tergast","year":"2019","unstructured":"Tergast TL, Kimmann M, Laser H, Gerbel S, Manns MP, Cornberg M, et al. Systemic arterial blood pressure determines the therapeutic window of nonselective beta blockers in decompensated cirrhosis. Aliment Pharmacol Ther. 2019;50:696\u2013706","journal-title":"Aliment Pharmacol Ther"},{"key":"10361_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/0016-5085(88)90441-6","volume":"94","author":"J Llach","year":"1988","unstructured":"Llach J, Gin\u00e8s P, Arroyo V, Rimola A, Tit\u00f3 L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology. 1988;94:482\u2013487","journal-title":"Gastroenterology"},{"key":"10361_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1053\/j.gastro.2021.04.077","volume":"161","author":"G Garcia-Tsao","year":"2021","unstructured":"Garcia-Tsao G, Abraldes JG. Nonselective beta-blockers in compensated cirrhosis: preventing variceal hemorrhage or preventing decompensation? Gastroenterology. 2021;161:770\u2013773","journal-title":"Gastroenterology"},{"key":"10361_CR20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/j.1478-3231.2009.02038.x","volume":"29","author":"M Senzolo","year":"2009","unstructured":"Senzolo M, Cholongitas E, Burra P, Leandro G, Thalheimer U, Patch D, et al. beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. Liver Int Off J Int Assoc Study Liver. 2009;29:1189\u20131193","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10361_CR21","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","volume":"38","author":"L Ruiz-del-Arbol","year":"2003","unstructured":"Ruiz-del-Arbol L, Urman J, Fern\u00e1ndez J, Gonz\u00e1lez M, Navasa M, Monescillo A, et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 2003;38:1210\u20131218","journal-title":"Hepatology"},{"key":"10361_CR22","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.jhep.2020.05.011","volume":"73","author":"L T\u00e9llez","year":"2020","unstructured":"T\u00e9llez L, Ib\u00e1\u00f1ez-Samaniego L, P\u00e9rez Del Villar C, Yotti R, Mart\u00ednez J, Carri\u00f3n L, et al. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites. J Hepatol. 2020;73:1404\u20131414","journal-title":"J Hepatol"},{"key":"10361_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jhep.2019.10.002","volume":"72","author":"V Giannelli","year":"2020","unstructured":"Giannelli V, Roux O, Laou\u00e9nan C, Manchon P, Ausloos F, Bachelet D, et al. impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation. J Hepatol. 2020;72:463\u2013471","journal-title":"J Hepatol"},{"key":"10361_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jhep.2011.04.033","volume":"56","author":"A Krag","year":"2012","unstructured":"Krag A, M\u00f8ller S, Burroughs AK, Bendtsen F. Betablockers induce cardiac chronotropic incompetence. J Hepatol. 2012;56:298\u2013299","journal-title":"J Hepatol"},{"key":"10361_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0168-8278(91)90807-N","volume":"13","author":"F Bendtsen","year":"1991","unstructured":"Bendtsen F, Henriksen JH, S\u00f8rensen TI. Propranolol and haemodynamic response in cirrhosis. J Hepatol. 1991;13:144\u2013148","journal-title":"J Hepatol"},{"key":"10361_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/gut.2009.180570","volume":"59","author":"A Krag","year":"2010","unstructured":"Krag A, Bendtsen F, Henriksen JH, M\u00f8ller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut. 2010;59:105\u2013110","journal-title":"Gut"},{"key":"10361_CR27","first-page":"1974","volume":"35","author":"T Serst\u00e9","year":"2015","unstructured":"Serst\u00e9 T, Njimi H, Degr\u00e9 D, Deltenre P, Schreiber J, Lepida A, et al. The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis. Liver Int Off J Int Assoc Study Liver. 2015;35:1974\u20131982","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10361_CR28","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","volume":"64","author":"JA Leithead","year":"2015","unstructured":"Leithead JA, Rajoriya N, Tehami N, Hodson J, Gunson BK, Tripathi D, et al. Nonselective \u03b2-blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut. 2015;64:1111\u20131119","journal-title":"Gut"},{"key":"10361_CR29","doi-asserted-by":"publisher","unstructured":"Gluud LL, Krag A. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database Syst Rev. 2012;(8):Cd004544. https:\/\/doi.org\/10.1002\/14651858.CD004544.pub2. PMID: 22895942","DOI":"10.1002\/14651858.CD004544.pub2."},{"key":"10361_CR30","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1001\/archinte.1984.00350210073012","volume":"144","author":"WG Rector Jr","year":"1984","unstructured":"Rector WG Jr, Reynolds TB. Propranolol in the treatment of cirrhotic ascites. Arch Intern Med. 1984;144:1761\u20131763","journal-title":"Arch Intern Med"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10361-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10361-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10361-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T08:33:05Z","timestamp":1659515585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10361-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10361"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10361-4","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"2 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Virendra Singh, Pramod Kumar, Nipun Verma, Rajesh Vijayvergiya, Akash Singh, and Ashish Bhalla declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal research (ethics)"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Declaration of Helsinki 1975, as revised in 2008. Institute Ethics Committee approved the protocol (INT\/IEC\/2015\/742).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate (ethics)"}},{"value":"Written informed consent was taken.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish (ethics)"}},{"value":"Trial was registered at clinicaltrials.gov NCT02649335.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trials registration"}}]}}